Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173740 | SCV000224888 | uncertain significance | not provided | 2017-03-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001085177 | SCV000650911 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000173740 | SCV001960516 | benign | not provided | 2019-10-16 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27296017, 28008999) |
Genetic Services Laboratory, |
RCV001818414 | SCV002069857 | likely benign | not specified | 2017-11-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000173740 | SCV002545555 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | FLNC: BS1 |
Ambry Genetics | RCV002399619 | SCV002709152 | likely benign | Cardiovascular phenotype | 2019-01-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003486724 | SCV004240615 | benign | Cardiomyopathy | 2023-05-16 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000173740 | SCV001929678 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000173740 | SCV001963685 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003917606 | SCV004731104 | likely benign | FLNC-related disorder | 2021-02-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |